Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 1.00 |
| ▸ | CA2 | P00918 | 6/20 | 1.00 |
| ▸ | CA4 | P22748 | 6/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.34 |
| ▸ | CA6 | P23280 | 4/20 | 0.33 |
| ▸ | SLC18A3 | Q16572 | 2/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.32 |
| ▸ | MT-CO1 | P00395 | 1/20 | 0.32 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18898271 | 1.00 | CA1 (1.00) | CA1CA2CA4CYP1A2ADRA2A | |
| SCHEMBL12512547 | 1.00 | CA1 (1.00) | CA1CA2CA4CYP1A2ADRA2A | |
| SCHEMBL12513262 | 1.00 | CA1 (1.00) | CA1CA2CA4CYP1A2ADRA2A | |
| SCHEMBL12727802 | 1.00 | CA1 (1.00) | CA1CA2CA4CYP1A2ADRA2A | |
| SCHEMBL4845315 | 0.98 | CA1 (0.95) | CA1CA2CA4CYP1A2ADRA2A | |
| SCHEMBL4843212 | 0.98 | CA1 (0.95) | CA1CA2CA4CYP1A2ADRA2A | |
| SCHEMBL4838403 | 0.95 | — | — | |
| SCHEMBL4640300 | 0.86 | CA1 (0.75) | CA1CA2CA4CYP1A2GBA1 | |
| SCHEMBL8754572 | 0.84 | CA1 (0.72) | CA1CA2CA4CYP1A2GBA1 | |
| SCHEMBL4843233 | 0.84 | CA1 (0.72) | CA1CA2CA4CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036506-A | Plasticizer, preparation method thereof and rubber material | 常州工学院 | 2026-05-15 | — | — | CN | claimed |
| CN-119060738-A | Synthesis method of liquid crystal compound containing alkoxy polyfluorobiphenyl | 安庆飞凯新材料有限公司 | 2024-12-03 | — | — | CN | claimed |
| CN-117326952-A | Method for synthesizing aniline | 华东理工大学 | 2024-01-02 | — | — | CN | claimed |
| WO-2023054999-A1 | METHOD FOR MANUFACTURING POLYALKYLENE CARBONATE RESIN | 주식회사 엘지화학 | 2023-04-06 | — | — | WO | claimed |
| WO-2023038406-A1 | DOUBLE METAL CYANIDE CATALYST, METHOD FOR PRODUCING SAME, AND METHOD FOR PREPARING POLYALKYLENE CARBONATE BY USING SAME CATALYST | 주식회사 엘지화학 | 2023-03-16 | — | — | WO | claimed |
| WO-2025121791-A1 | POLYALKYLENE CARBONATE-BASED RESIN AND METHOD FOR PRODUCING SAME | 주식회사 엘지화학 | 2025-06-12 | — | — | WO | disclosed |
| CN-119060738-A | Synthesis method of liquid crystal compound containing alkoxy polyfluorobiphenyl | 安庆飞凯新材料有限公司 | 2024-12-03 | — | — | CN | disclosed |
| WO-2024232726-A1 | POLYALKYLENE CARBONATE RESIN COMPOSITION AND PREPARATION METHOD THEREFOR | 주식회사 엘지화학 | 2024-11-14 | — | — | WO | disclosed |
| WO-2024232724-A1 | POLYALKYLENE CARBONATE RESIN COMPOSITION AND PREPARATION METHOD THEREFOR | 주식회사 엘지화학 | 2024-11-14 | — | — | WO | disclosed |
| WO-2024167274-A1 | POLYALKYLENE CARBONATE RESIN COMPOSITION AND PREPARATION METHOD THEREFOR | 주식회사 엘지화학 | 2024-08-15 | — | — | WO | disclosed |
| CN-118126304-A | Polycarbonate copolymer and preparation method and application thereof | 华东理工大学 | 2024-06-04 | — | — | CN | disclosed |
| CN-117426473-A | Preparation method of salix mongolica water extract, preparation method of salix mongolica flavor seasoning and application of salix mongolica flavor seasoning | 黄山学院 | 2024-01-23 | — | — | CN | disclosed |
| US-20090068584-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, CURED LAYER, PROTECTING LAYER, INSULATING LAYER AND SEMICONDUCTOR DEVICE AND DISPLAY THEREWITH | SUMITOMO BAKELITE CO., LTD. (JP) | 2009-03-12 | — | — | US | disclosed |
| CN-101356150-A | Process for continuous preparation of a primary aromatic amine | BASF SE (DE) | 2009-01-28 | — | — | CN | disclosed |
| US-7332632-B2 | Method for producing aldehyde compound or ketone compound by using microreactor | Ubē Industries, Ltd. (JP) | 2008-02-19 | — | — | US | disclosed |
| US-20070149823-A1 | Method for producing aldehyde compound or ketone compound by using microreactor | UBE INDUSTRIES, LTD., A CORPORATION OF JAPAN (JP) | 2007-06-28 | — | — | US | disclosed |
| EP-1710223-A1 | PROCESS FOR PRODUCING ALDEHYDE COMPOUND OR KETONE COMPOUND WITH USE OF MICROREACTOR | Ube Industries, Ltd. (JP) | 2006-10-11 | — | — | EP | disclosed |
| CN-1777823-A | Resin composition for hybrid lens, method for producing hybrid lens, hybrid lens and lens system | SEIKO EPSON CORP (JP) | 2006-05-24 | — | — | CN | disclosed |
| CN-1571788-A | Photoactivable nitrogen bases | CIBA SC HOLDING AG (CH) | 2005-01-26 | — | — | CN | disclosed |
| EP-0038471-A1 | Beta-gamma-unsaturated ketones and isoprenoic dienones, process for their preparation and their use as perfume compounds and flavourings | Consortium für elektrochemische Industrie GmbH (DE) | 1981-10-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070149823-A1 | Method for producing aldehyde compound or ketone compound by using microreactor | ADH1C, ADH1A, ALDH1A1 | CA1 1026/4885CA2 2767/4885CA4 1056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.